SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is drawing attention over the FTC and more than 20 state attorneys general suing over alleged manipulation of sponsored-ad auction pricing and hidden fees. Traders are split between concerns about legal costs, restrictions and pressure on the high-margin advertising business, and views that the selloff is a buying opportunity given Amazons AWS and AI growth.

Edison International is a renewable energy company, which operates through its subsidiaries. It supplies and distributes electric power, and also invests in energy services and technologies. The company was founded on July 4, 1886, and is headquartered in Rosemead, CA.

Edison International

Californias latest wildfire legislation failed to provide the liability protections investors expected, leaving Edison International exposed to potentially significant wildfire claims and prompting analyst downgrades. Traders are divided between bearish views that unresolved liability could pressure the balance sheet and dividend, and bullish arguments that the selloff is an overreaction to a temporarily oversold utility with long-term value.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Anticipation of Teslas Cybercab launch and reported expansion of its driverless Robotaxi fleet in Texas are driving attention, with traders viewing the developments as validation of the autonomy strategy and fueling bullish momentum and short-squeeze speculation. Skeptics argue the move is event-driven hype, citing valuation, limited current monetization, and concerns about Teslas camera-only self-driving approach, while expecting a potential sell-the-news reaction.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Bitcoins sharp breakout and broader crypto rally are driving attention to Coinbase, with traders expecting higher transaction activity and renewed upside while positioning for a short squeeze. The community is divided between bullish momentum and concerns that hawkish rate expectations, profit-taking, and Coinbases recent lag versus Bitcoin could trigger another pullback.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is drawing attention ahead of its scheduled fiscal fourth-quarter earnings report, with traders focused on whether its platformization strategy, ARR growth and fiscal 2027 guidance can support continued cybersecurity momentum. Bulls expect a beat and stronger outlook, while skeptics argue the recent rally has left valuation elevated and the stock vulnerable to a sell-the-news reaction.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

A broader crypto-market rebound and anticipation of progress on the U.S. Clarity Act are driving attention, with traders also citing Circles stablecoin adoption and upcoming Arc blockchain launch. Bulls view regulatory clarity and growing payments use as long-term tailwinds, while skeptics point to bank-issued stablecoins, declining USDC supply and elevated valuation as risks.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

A post-SpaceX IPO reset and capital rotation out of high-beta space stocks have driven Planet Labs sharp drawdown, with traders also citing the ATM offering and limited management updates. Attention is now focused on the scheduled earnings report as a potential test of the turnaround, while the community remains split between an oversold buying opportunity and further downside if results disappoint.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

AI-driven memory demand, tight HBM supply, and anticipation of upcoming earnings are fueling bullish interest in Micron, with Michael Burrys disclosed short adding to the debate. Traders remain divided between expectations of stronger memory pricing and an earnings-driven re-rating versus concerns that cyclical peak conditions, valuation, Chinese competition, and macro risks are already priced in.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

GTA VIs extended gameplay preview and a wave of unauthorized leaks are driving attention, with traders debating whether the footage signals performance, monetization, or delay risks ahead of launch. Bulls view the selloff as an overreaction and emphasize strong demand and preorder speculation, while bears argue the game may be overhyped or unfinished.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

Hawkish Federal Reserve signals have lifted rate-hike expectations and Treasury yields, pressuring the Dow while traders debate whether persistent inflation and Middle East-driven oil risks will trigger a broader correction. Some participants expect the Fed to remain on hold and support a rebound, but the dominant tone is cautious amid bond-market stress and seasonal weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

No specific company, sector, or macro catalyst clearly explains the move, which appears tied to broader trading activity.

Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves

Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing cancer-focused therapies and technologies.

Zacks Industry Outlook Halozyme, Repligen, Iovance, Arcutis and Precigen 

Halozyme, Repligen, Iovance, Arcutis and Precigen have been highlighted in this Industry Outlook article.


5 Biotech Stocks Worth Adding to Your Portfolio Now 

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position HALO, RGEN, IOVA, ARQT and PGEN in this volatile sector. 

Iovance Biotherapeutics Stock Is Trending Friday: What's Going On?

Shares of Iovance Biotherapeutics are trending Friday morning after a momentum surge pushed the biotech stock to a new 52-week high.read more...

Why Did IOVA, AMLX And COP Stocks Surge To 52-Week Highs Today? 

Equity

Strong results, clinical progress, capital raises and bullish analyst calls boosted investor confidence. 


IOVA Stock Hits Fresh 52-Week Peak On UBS Target Hike, Melanoma Sector Optimism

UBS analyst David Dai raised the firm’s price target on IOVA to $7 from $4 on Thursday while maintaining a Neutral rating.


Why Iovance Biotherapeutics Stock Hit 52-Week High

Iovance Biotherapeutics stock hits a 52-week high as investors weigh Moderna-Merck cancer data, Amtagvi sales and analyst price target hikes.read more...

Here's Why Iovance Biotherapeutics (IOVA) is a Great Momentum Stock to Buy

Does Iovance Biotherapeutics (IOVA) have what it takes to be a top stock pick for momentum investors? Let's find out.

IOVA Stock Hits New 52-Week High As Shares Jump 14% — What Drove The Rally? 

IOVA’s rally coincides with positive sentiment across melanoma-focused biotech stocks after Merck and Moderna announced successful late-stage data for their personalized mRNA cancer vaccine on Wednesday.


Why Did AMLX, IOVA, OKE Stocks Hit 52-Week Highs Today? 

Investors responded to clinical progress, improving commercial performance and new growth opportunities.


• Reported GAAP EPS of -$0.11 up 66.67% YoY
• Reported revenue of $198.63M up 231.31% YoY
• Iovance Biotherapeutics is reviewing its previously issued 2026 total revenue guidance of $350 million to $370 million based on strong second-quarter sales and current demand trends, with an update expected later.

Iovance Biotherapeutics reported a quarterly net loss and faces operational risks regarding manufacturing capacity expansion, while management cautioned that certain metrics may not reliably predict future Amtagvi revenue performance.

Iovance Biotherapeutics delivered record revenue and improved gross margins through strong Amtagvi demand and manufacturing efficiencies, while advancing its clinical pipeline with new FDA Fast Track Designations for novel therapies.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Retail investors are actively speculating on a potential partnership or buyout following a recent UAE embassy tour of Iovance manufacturing facilities.

Market experts highlight that impending 2028 pharmaceutical patent cliffs make companies like Iovance prime targets for multibillion-dollar acquisition interest.

The upcoming Q4 NSCLC trial data is viewed as a pivotal moment for potentially expanding Iovance into a much larger multi-tumor commercial platform.

Traders are closely watching the $8 support level as evidence of healthy consolidation after recent volatility and strong institutional buying.

Deep divisions persist between long-term investors tracking institutional shifts and retail traders increasingly frustrated by social media pump-and-dump dynamics.

Feed

News

Sentiment

Earnings

Fundamentals

Info